1. FDA Committee Votes 6-6 on Durect's Non-Opioid Pain Drug — Eli Lilly targets quarterly deals of $1 billion-$5 billion in 2020 — Novo Nordisk's Ozempic wins FDA label boost with CV indication — See more on our front page news TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Why so negative?

Discussion in 'Dura' started by Anonymous, May 5, 2012 at 8:43 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    I was at Dura 1990 - 1993, loved working there, especially working for Walt. Most of these postings are so toxic, what's up with that?